TY - JOUR TI - Driving cancer evolution AU - Fitzgerald, Devon M AU - Rosenberg, Susan M VL - 6 PY - 2017 DA - 2017/03/10 SP - e25431 C1 - eLife 2017;6:e25431 DO - 10.7554/eLife.25431 UR - https://doi.org/10.7554/eLife.25431 AB - Tumor-growth-factor-beta signaling helps cancer cells to evolve and become resistant to drugs by down-regulating accurate DNA repair. KW - genetic diversity KW - drug adaptability KW - intra-tumor heterogeneity KW - tumor evolution KW - tumor fitness KW - copy number alteration JF - eLife SN - 2050-084X PB - eLife Sciences Publications, Ltd ER -